Kurome Therapeutics
Guillermo Garcia-Manero as Deputy Chair at Department of Leukemia, Chief at Section of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia ), University of Texas MD Anderson Cancer Center, Houston, TX. He is also the Chair, Faculty Senate at University of Texas MD Anderson Cancer Center, Houston, TX
This person is not in the org chart
This person is not in any offices
Kurome Therapeutics
Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.